Literature DB >> 1771208

Hard neurologic signs and psychopathology in relatives of schizophrenic patients.

D K Kinney1, D A Yurgelun-Todd, B T Woods.   

Abstract

Previous research found more hard neurologic signs (i.e., signs that have localizing significance and exclude likely artifacts) in the nonschizophrenic relatives of schizophrenic patients than in control subjects, and in the psychiatrically normal relatives of schizophrenic patients compared with their ill relatives. Using interview-based DSM-III-R diagnoses and standard clinical neurological examinations on new samples, we found a trend to more hard signs in the 52 nonschizophrenic relatives of schizophrenic patients than in 20 control subjects, and significantly more signs in psychiatrically normal relatives than in ill ones. When pooled with previous data, signs were significantly higher in (1) relatives vs. controls and (2) normal vs. ill relatives, suggesting neurologic signs reflect an etiologic factor that often runs in families of schizophrenic patients.

Entities:  

Mesh:

Year:  1991        PMID: 1771208     DOI: 10.1016/0165-1781(91)90007-c

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Exploring online communication about cigarette smoking among Twitter users who self-identify as having schizophrenia.

Authors:  Yulin Hswen; John A Naslund; Pooja Chandrashekar; Robert Siegel; John S Brownstein; Jared B Hawkins
Journal:  Psychiatry Res       Date:  2017-08-02       Impact factor: 3.222

2.  Neurological soft signs in schizophrenia: assessment and correlates.

Authors:  F Mohr; W Hubmann; R Cohen; W Bender; C Haslacher; S Hönicke; R Schlenker; C Wahlheim; P Werther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

3.  Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.

Authors:  Jeroen P F Koning; Diederik E Tenback; Jim van Os; André Aleman; René S Kahn; Peter N van Harten
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.